Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans

计划入组 60 人 · 首次发布于 2017 年 1 月 13 日

Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities

首次发布于 2009 年 10 月 9 日

Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

计划入组 48 人 · 首次发布于 2025 年 1 月 29 日

DNA vaccine (National Institutes of Health/Karolinska Institutet)

Crimean Congo Hemorrhagic Fever Vaccine( Karolinska Institutet)

monoclonal antibody (Crimean-Congo haemorrhagic fever)

Suzhou Zelgen Biopharmaceuticals Co., Ltd

Abivax S.A.

France

AIM VACCINE

China

FDA Clears HDT Bio's First-in-Class HDT-321 for Crimean-Congo Hemorrhagic Fever Prevention

Two NIH Researchers Arrested for Allegedly Smuggling Monkeypox Virus Samples into the United States

Structures and Nucleotide Analog Inhibition of the CCHFV Polymerase Reveal Sofosbuvir-Like Compounds as Potent Chain Terminators